Evidence map

ArticleThe New England journal of medicine2022

Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes.

Gaetano SantulliPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35172066